Continued approval for this indication is dependent on confirmation of clinical benefit in a clinical trial
Most insurance companies treat weight-loss medications like cosmetic surgery, nice to have, but not medically necessary
No other potential competing interests relevant to this article are reported
The Short Answer Tirzepatide (Mounjaro/Zepbound) drives more weight loss than semaglutide (Ozempic/Wegovy) about 6.5 percentage points more in a head-to-head trial (-20.2% vs -13.7% over 72 weeks in adults with obesity without diabetes)
Specific care in Dubai: In Dubai, the most crucial aftercare, especially in summer, is to protect yourself from extreme heat and sun exposure
Gynecol Oncol 147:351357 Vaccaro M, Coppola M, Lentini M et al (2022) Spitz nevus of the vulva: a very rare presentation of the genital region